Paeds SAQs · cardiology
Ebstein anomaly and tricuspid valve disease — formative SAQs
Two formative SAQs on Ebstein anomaly and tricuspid valve disease in children: the severely cyanosed neonate with a wall-to-wall heart, functional pulmonary atresia and metabolic acidosis, testing the prostaglandin-E1-first rule, the GOSE-scored severity grading and the cone-versus-Starnes surgical decision; and the adolescent with previously undiagnosed Ebstein presenting with palpitations, pre-excitation on the ECG and an accessory pathway, testing the arrhythmia link, the lifelong surveillance and the transition to adult congenital heart disease services.
On this page
Study tools
Target exams
SAQ 1 — The cyanosed neonate with a wall-to-wall heart (10 marks, 15 minutes)
A two-day-old term infant presents with deep central cyanosis that does not improve with supplemental oxygen. On examination the precordium is hyperdynamic, there is a loud scratching pansystolic murmur at the lower left sternal edge, and the liver is palpable four centimetres below the costal margin. The chest X-ray shows a massively enlarged heart with diminished pulmonary vascular markings. A diagnosis of severe Ebstein anomaly with functional pulmonary atresia is suspected. [5]
a) Explain why this infant is cyanosed, and why the cyanosis does not improve with oxygen. (3 marks) [2]
b) Outline your immediate resuscitation, naming the specific drug, its dose and its mechanism of action. State the most important side effect and how you would manage it during retrieval to a cardiac centre. (5 marks) [3]
c) Describe how the neonatal echocardiographic severity is graded, and how the grade changes the surgical plan. (2 marks) [10]
References12ShowHide
- [1]Ramcharan TKW; Goff DA; Greenleaf CE; et al Ebstein's Anomaly: From Fetus to Adult-Literature Review and Pathway for Patient Care. Pediatr Cardiol, 2022.PMID 35460366
- [2]Pasqualin G; Boccellino A; Chessa M; et al Ebstein's anomaly in children and adults: multidisciplinary insights into imaging and therapy. Heart, 2024.PMID 37487694
- [3]Konstantinov IE; Chai P; Bacha E; et al The American Association for Thoracic Surgery (AATS) 2024 expert consensus document: Management of neonates and infants with Ebstein anomaly. J Thorac Cardiovasc Surg, 2024.PMID 38685467
- [4]Holst KA; Connolly HM; Dearani JA Ebstein's Anomaly. Methodist Debakey Cardiovasc J, 2019.PMID 31384377
- [5]Galea J; Ellul S; Schembri A; et al Ebstein anomaly: a review. Neonatal Netw, 2014.PMID 25161135
- [6]Burri M; Mrad Agua K; Cleuziou J; et al Cone versus conventional repair for Ebstein's anomaly. J Thorac Cardiovasc Surg, 2020.PMID 32711971
- [7]Neumann S; Rüffer A; Sachweh J; et al Narrative review of Ebstein's anomaly beyond childhood: Imaging, surgery, and future perspectives. Cardiovasc Diagn Ther, 2021.PMID 35070800
- [8]da Silva JP; Baumgratz JF; da Fonseca L; et al The cone reconstruction of the tricuspid valve in Ebstein's anomaly. The operation: early and midterm results. J Thorac Cardiovasc Surg, 2007.PMID 17198815
- [9]Delhaas T; Sarvaas GJ; Rijlaarsdam ME; et al A multicenter, long-term study on arrhythmias in children with Ebstein anomaly. Pediatr Cardiol, 2010.PMID 19937010
- [10]Yu JJ; Yun TJ; Won HS; et al Outcome of neonates with Ebstein's anomaly in the current era. Pediatr Cardiol, 2013.PMID 23494543
- [11]Thareja SK; Frommelt MA; Lincoln J; et al A Systematic Review of Ebstein's Anomaly with Left Ventricular Noncompaction. J Cardiovasc Dev Dis, 2022.PMID 35448091
- [12]Kumar SR; Kung G; Noh N; et al Single-Ventricle Outcomes After Neonatal Palliation of Severe Ebstein Anomaly With Modified Starnes Procedure. Circulation, 2016.PMID 27777295